Its presence in the precursor condition (IgM-MGUS) suggests that is a ‘driver mutation’ or tumor-initiating event, which might provide the early tumor clone a competitive growth advantage and predispose it toward further genetic alterations, since it is insufficient by itself for the full development of lymphomas [48,49]. This evidence concerns the gene CD40LG and lymphoma.